NASDAQ : AYTU
Aytu BioPharma, Inc. — Financial statements
Healthcare · Drug Manufacturers - Specialty & Generic · United States
Last price 1.93 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 20.97M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Aytu BioPharma, Inc. (AYTU) reported revenue of 57.57M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year July - June; amounts in USD.
| TTM | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|---|
| Revenue | 57.57M | 57.57M | 66.38M | 65.18M | 73.80M | 96.67M |
| Cost of Revenue | 20.75M | 20.75M | 20.55M | 16.13M | 21.57M | 46.39M |
| Gross Profit | 36.82M | 36.82M | 45.83M | 49.05M | 52.23M | 50.28M |
| Selling, General & Admin | 42.64M | 42.64M | 38.28M | 42.04M | 49.77M | 69.88M |
| Research & Development | 1.33M | 2.77M | 3.98M | 12.66M | ||
| Amortization of Goodwill & Intangibles | 2.49M | 2.49M | 3.68M | 3.68M | 3.69M | 5.84M |
| Operating Expenses | 45.13M | 45.13M | 43.29M | 48.49M | 57.44M | 88.39M |
| Operating Income | -8.31M | -8.31M | 2.54M | 565.00K | -5.21M | -38.10M |
| Interest Expense | -1.90M | -1.90M | -3.70M | -5.06M | -5.15M | -14.00K |
| Other Non Operating Income (Expenses) | -4.02M | -4.02M | -2.21M | -3.13M | 5.22M | 862.00K |
| EBT Excluding Unusual Items | -14.23M | -14.23M | -3.38M | -7.63M | -5.14M | -37.26M |
| Merger & Restructuring Charges | -2.10M | -2.16M | ||||
| Impairment of Goodwill | -65.80M | |||||
| Asset Writedown | -8.26M | -2.73M | -7.66M | |||
| Other Unusual Items | -594.00K | 578.00K | 1.82M | |||
| Pretax Income | -14.23M | -14.23M | -13.74M | -10.38M | -7.29M | -108.89M |
| Income Tax Expense | 21.00K | 21.00K | 437.00K | 2.14M | 263.00K | -110.00K |
| Earnings From Continuing Operations | -14.25M | -14.25M | -14.18M | -12.52M | -7.55M | -108.78M |
| Earnings From Discontinued Operations | 620.00K | -3.32M | -9.50M | |||
| Net Income | -14.25M | -14.25M | -13.56M | -15.84M | -17.05M | -108.78M |
| Net Income to Common | -14.25M | -14.25M | -13.56M | -15.84M | -17.05M | -108.78M |
| Shares Outstanding (Basic) | 12.32M | 12.32M | 6.28M | 5.54M | 3.34M | 1.47M |
| Shares Outstanding (Diluted) | 12.32M | 12.32M | 6.28M | 5.54M | 3.34M | 1.47M |
| EPS (Basic) | -1.16 | -1.16 | -2.16 | -2.86 | -5.11 | -74.01 |
| EPS (Diluted) | -1.16 | -1.16 | -2.16 | -2.86 | -5.11 | -74.01 |
| Free Cash Flow | 3.25M | 3.25M | -2.17M | -1.72M | -5.13M | -28.82M |
| Free Cash Flow Per Share | 0.26 | 0.26 | -0.34 | -0.31 | -1.54 | -19.61 |
| Gross Margin | 63.95% | 63.95% | 69.04% | 75.26% | 70.77% | 52.02% |
| Operating Margin | -14.44% | -14.44% | 3.82% | 0.87% | -7.05% | -39.42% |
| Profit Margin | -24.76% | -24.76% | -20.43% | -24.31% | -23.11% | -112.53% |
| Free Cash Flow Margin | 5.65% | 5.65% | -3.26% | -2.63% | -6.95% | -29.82% |
| EBITDA | -4.38M | -4.38M | 7.91M | 7.29M | 2.49M | -27.96M |
| EBITDA Margin | -7.62% | -7.62% | 11.92% | 11.18% | 3.38% | -28.92% |
| D&A For EBITDA | 3.93M | 3.93M | 5.38M | 6.72M | 7.70M | 10.15M |
| EBIT | -8.31M | -8.31M | 2.54M | 565.00K | -5.21M | -38.10M |
| EBIT Margin | -14.44% | -14.44% | 3.82% | 0.87% | -7.05% | -39.42% |
| Advertising Expenses | 13.60M |
Balance sheet
Fiscal year July - June; amounts in USD.
| TTM | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 26.31M | 26.31M | 30.95M | 20.01M | 22.98M | 19.36M |
| Cash & Short-Term Investments | 26.31M | 26.31M | 30.95M | 20.01M | 22.98M | 19.36M |
| Receivables | 22.78M | 22.78M | 31.16M | 23.53M | 28.73M | 21.71M |
| Inventory | 6.86M | 6.86M | 11.43M | 12.14M | 8.51M | 10.85M |
| Prepaid Expenses | 5.81M | 5.81M | 5.64M | 5.10M | 5.43M | 7.38M |
| Other Current Assets | 1.12M | 5.43M | 633.00K | |||
| Total Current Assets | 61.76M | 61.76M | 79.18M | 61.89M | 71.08M | 59.93M |
| Property, Plant & Equipment | 1.24M | 1.24M | 1.59M | 1.52M | 3.61M | 6.30M |
| Other Intangible Assets | 41.40M | 41.40M | 42.20M | 52.45M | 57.44M | 70.63M |
| Long-Term Deferred Tax Assets | 200.00K | 200.00K | 252.00K | 762.00K | 1.38M | |
| Other Long-Term Assets | 401.00K | 401.00K | 952.00K | 1.47M | 2.96M | 766.00K |
| Total Assets | 105.01M | 105.01M | 124.18M | 118.09M | 136.46M | 137.62M |
| Accounts Payable | 11.28M | 11.28M | 10.60M | 10.31M | 12.55M | 10.99M |
| Accrued Expenses | 14.18M | 14.18M | 15.26M | 22.26M | 24.54M | 25.71M |
| Short-Term Debt | 6.07M | 6.07M | 9.06M | 2.40M | 1.56M | 3.81M |
| Current Portion of Long-Term Debt | 1.86M | 1.86M | 1.86M | 1.86M | ||
| Current Portion of Leases | 221.00K | 221.00K | 137.00K | 712.00K | 1.34M | 96.00K |
| Other Current Liabilities | 21.04M | 21.04M | 26.14M | 24.69M | 29.02M | 23.84M |
| Total Current Liabilities | 54.66M | 54.66M | 63.06M | 62.23M | 69.02M | 64.44M |
| Long-Term Debt | 9.10M | 9.10M | 10.89M | 10.88M | 14.71M | 14.20M |
| Long-Term Leases | 853.00K | 853.00K | 985.00K | 577.00K | 832.00K | 84.00K |
| Long-Term Deferred Tax Liabilities | 200.00K | 200.00K | 252.00K | 762.00K | 1.38M | |
| Other Long-Term Liabilities | 4.92M | 4.92M | 30.02M | 15.94M | 11.17M | 14.59M |
| Total Liabilities | 69.73M | 69.73M | 105.21M | 90.38M | 97.11M | 93.31M |
| Common Stock | 1.00K | 1.00K | 1.00K | 1.00K | 1.00K | |
| Additional Paid-In Capital | 383.06M | 383.06M | 352.50M | 347.69M | 343.49M | 331.39M |
| Retained Earnings | -347.79M | -347.79M | -333.54M | -319.97M | -304.13M | -287.08M |
| Total Common Equity | 35.27M | 35.27M | 18.97M | 27.72M | 39.36M | 44.31M |
| Shareholders' Equity | 35.27M | 35.27M | 18.97M | 27.72M | 39.36M | 44.31M |
| Total Liabilities & Equity | 105.01M | 105.01M | 124.18M | 118.09M | 136.46M | 137.62M |
| Total Debt | 18.11M | 18.11M | 22.94M | 16.42M | 18.45M | 18.19M |
| Net Cash (Debt) | 8.20M | 8.20M | 8.02M | 3.59M | 4.53M | 1.17M |
| Net Cash Per Share | 0.67 | 0.67 | 1.28 | 0.65 | 1.36 | 0.80 |
| Filing Date Shares Outstanding | 10.87M | 10.87M | 9.91M | 6.17M | 5.53M | 3.12M |
| Total Common Shares Outstanding | 10.73M | 10.73M | 8.98M | 5.97M | 5.52M | 1.93M |
| Working Capital | 7.10M | 7.10M | 16.11M | -337.00K | 2.06M | -4.51M |
| Book Value Per Share | 3.29 | 3.29 | 2.11 | 4.64 | 7.13 | 22.97 |
| Tangible Book Value | -6.13M | -6.13M | -23.23M | -24.74M | -18.08M | -26.32M |
| Tangible Book Value Per Share | -0.57 | -0.57 | -2.59 | -4.14 | -3.28 | -13.65 |
| Machinery | 1.03M | 1.03M | 1.08M | 2.78M | 4.29M | 4.45M |
| Construction In Progress | 107.00K | |||||
| Leasehold Improvements | 164.00K | 164.00K | 164.00K | 35.00K | 999.00K | 999.00K |
Cash flow statement
Fiscal year July - June; amounts in USD.
| TTM | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|---|
| Net Income | -14.25M | -14.25M | -13.56M | -15.84M | -17.05M | -108.78M |
| Depreciation & Amortization | 3.93M | 3.93M | 5.38M | 6.72M | 7.70M | 10.15M |
| Other Amortization | 113.00K | 113.00K | 108.00K | 597.00K | 559.00K | |
| Asset Writedown & Restructuring Costs | 8.26M | 2.73M | 75.46M | |||
| Stock-Based Compensation | 691.00K | 691.00K | 576.00K | 2.37M | 5.72M | 5.25M |
| Other Operating Activities | 6.96M | 6.96M | 2.78M | 6.06M | -5.17M | -33.00K |
| Change in Accounts Receivable | 8.38M | 8.38M | -7.63M | 5.20M | -7.24M | 6.53M |
| Change in Inventory | 2.39M | 2.39M | 382.00K | -4.82M | -3.49M | 1.30M |
| Change in Accounts Payable | -2.32M | -2.32M | 287.00K | -2.08M | 3.09M | -7.68M |
| Change in Other Net Operating Assets | -2.61M | -2.61M | 963.00K | -5.03M | 2.65M | -11.01M |
| Operating Cash Flow | 3.28M | 3.28M | -1.94M | -1.39M | -5.13M | -28.82M |
| Capital Expenditures | -29.00K | -29.00K | -228.00K | -329.00K | ||
| Sale of Property, Plant & Equipment | 668.00K | |||||
| Cash Acquisitions | -3.18M | |||||
| Sale (Purchase) of Intangibles | -3.00M | |||||
| Other Investing Activities | -117.00K | -70.00K | ||||
| Investing Cash Flow | -29.00K | -29.00K | -2.56M | -329.00K | -117.00K | -3.25M |
| Short-Term Debt Issued | 6.67M | 832.00K | ||||
| Long-Term Debt Issued | 1.86M | 13.00M | 15.00M | |||
| Total Debt Issued | 8.53M | 13.83M | 15.00M | |||
| Short-Term Debt Repaid | -2.99M | -2.99M | -2.25M | -4.12M | ||
| Long-Term Debt Repaid | -1.86M | -1.86M | -1.86M | -15.72M | -96.00K | -16.10M |
| Total Debt Repaid | -4.85M | -4.85M | -1.86M | -15.72M | -2.35M | -20.22M |
| Net Debt Issued (Repaid) | -4.85M | -4.85M | 6.67M | -1.89M | -2.35M | -5.22M |
| Issuance of Common Stock | 14.84M | 3.47M | 15.57M | 11.69M | ||
| Other Financing Activities | -3.05M | -3.05M | -6.07M | -2.84M | -4.36M | -4.94M |
| Financing Cash Flow | -7.90M | -7.90M | 15.44M | -1.26M | 8.87M | 1.53M |
| Net Cash Flow | -4.64M | -4.64M | 10.95M | -2.98M | 3.62M | -30.54M |
| Free Cash Flow | 3.25M | 3.25M | -2.17M | -1.72M | -5.13M | -28.82M |
| Free Cash Flow Margin | 5.65% | 5.65% | -3.26% | -2.63% | -6.95% | -29.82% |
| Free Cash Flow Per Share | 0.26 | 0.26 | -0.34 | -0.31 | -1.54 | -19.61 |
| Levered Free Cash Flow | 5.60M | 5.60M | -9.49M | 3.92M | 5.56M | -17.72M |
| Unlevered Free Cash Flow | 6.67M | 6.67M | -7.29M | 6.49M | 8.22M | -17.71M |
| Cash Interest Paid | 1.79M | 1.79M | 2.82M | 4.04M | 3.81M | 3.15M |
| Cash Income Tax Paid | 211.00K | 211.00K | 1.42M | 1.61M | ||
| Change in Working Capital | 5.83M | 5.83M | -6.00M | -6.73M | -4.99M | -10.86M |
Ratios
Fiscal year July - June; amounts in USD.
| TTM | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 20.97M | 23.08M | 19.57M | 17.44M | 8.84M | 26.62M |
| Enterprise Value | 12.77M | 19.30M | 23.92M | 16.31M | 14.75M | 20.26M |
| Last Close Price | 1.93 | 2.15 | 2.18 | 2.92 | 1.60 | 13.80 |
| Forward PE | 9.03 | 9.03 | ||||
| PS Ratio | 0.36 | 0.40 | 0.29 | 0.27 | 0.12 | 0.28 |
| PB Ratio | 0.59 | 0.65 | 1.03 | 0.63 | 0.23 | 0.60 |
| P/FCF Ratio | 6.45 | 7.10 | ||||
| P/OCF Ratio | 6.39 | 7.03 | ||||
| EV/Sales Ratio | 0.22 | 0.34 | 0.36 | 0.25 | 0.20 | 0.21 |
| EV/EBITDA Ratio | 3.02 | 2.24 | 5.92 | |||
| EV/EBIT Ratio | 9.43 | 28.87 | ||||
| EV/FCF Ratio | 3.93 | 5.93 | ||||
| Debt / Equity Ratio | 0.51 | 0.51 | 1.21 | 0.59 | 0.47 | 0.41 |
| Debt / EBITDA Ratio | 2.68 | 1.75 | 4.68 | |||
| Debt / FCF Ratio | 5.57 | 5.57 | ||||
| Net Debt / Equity Ratio | -0.23 | -0.23 | -0.42 | -0.13 | -0.12 | -0.03 |
| Net Debt / EBITDA Ratio | 1.87 | 1.87 | -1.01 | -0.49 | -1.82 | 0.04 |
| Net Debt / FCF Ratio | -2.52 | -2.52 | 3.70 | 2.09 | 0.88 | 0.04 |
| Asset Turnover | 0.50 | 0.50 | 0.55 | 0.51 | 0.54 | 0.48 |
| Inventory Turnover | 2.27 | 2.27 | 1.74 | 1.56 | 2.23 | 3.41 |
| Quick Ratio | 0.90 | 0.90 | 0.98 | 0.70 | 0.75 | 0.64 |
| Current Ratio | 1.13 | 1.13 | 1.26 | 0.99 | 1.03 | 0.93 |
| Return on Equity (ROE) | -52.55% | -52.55% | -60.76% | -37.33% | -18.05% | -119.62% |
| Return on Assets (ROA) | -4.54% | -4.54% | 1.31% | 0.28% | -2.37% | -11.81% |
| Return on Capital Employed (ROCE) | -16.50% | -16.50% | 4.20% | 1.00% | -7.70% | -52.10% |
| Earnings Yield | -59.94% | -61.76% | -69.30% | -90.85% | -192.92% | -408.69% |
| FCF Yield | 15.51% | 14.09% | -11.06% | -9.85% | -58.03% | -108.29% |
| Buyback Yield / Dilution | -96.17% | -96.17% | -13.40% | -65.81% | -127.22% | -75.54% |